
Advanced Marker Discovery SL - Product Pipeline Analysis, 2023 Update
Description
Summary
Advanced Marker Discovery SL (Amadix) is a developer and discoverer of cancer diagnostic products. The company provides test products and diagnostic tools for lung cancer, colon cancer and prostate cancer. It offers diagnostic tools that support the physician’s decisions about patient management. Amadix provides discovery, clinical validation, assay development, clinical utility, commercialization, in licensing and out licensing services. The company identifies, evaluates and in-licenses breakthrough discoveries in cancer diagnosis and develops them into marketable products. Its diagnostic tool offers prognostic, predictive and screening solutions, among others. The company sells products through a network of distributors in Spain. Amadix is headquartered in Valladolid, Spain.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Advanced Marker Discovery SL
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
31 Pages
- Advanced Marker Discovery SL Company Overview
- Advanced Marker Discovery SL Company Snapshot
- Advanced Marker Discovery SL Pipeline Products and Ongoing Clinical Trials Overview
- Advanced Marker Discovery SL – Pipeline Analysis Overview
- Advanced Marker Discovery SL - Key Facts
- Advanced Marker Discovery SL - Major Products and Services
- Advanced Marker Discovery SL Pipeline Products by Development Stage
- Advanced Marker Discovery SL Pipeline Products Overview
- 2nd Generation Prostate Cancer Test
- 2nd Generation Prostate Cancer Test Product Overview
- 3rd Generation Prostate Cancer Test
- 3rd Generation Prostate Cancer Test Product Overview
- 4th Generation Prostate Cancer Test
- 4th Generation Prostate Cancer Test Product Overview
- Biomarker Diagnostic Test - Ovarian Cancer
- Biomarker Diagnostic Test - Ovarian Cancer Product Overview
- DiagnoLung
- DiagnoLung Product Overview
- PancreaDix
- PancreaDix Product Overview
- Predictive Diagnostic Test - Lung Cancer
- Predictive Diagnostic Test - Lung Cancer Product Overview
- PreveCol
- PreveCol Product Overview
- Prognostic And Predictive Test - Colon cancer
- Prognostic And Predictive Test - Colon cancer Product Overview
- Prognostic Test - Lung Cancer
- Prognostic Test - Lung Cancer Product Overview
- Prognostic Test - Prostate Cancer
- Prognostic Test - Prostate Cancer Product Overview
- Prostate Cancer - Genetic Test
- Prostate Cancer - Genetic Test Product Overview
- Urine Based Diagnostic Test - Prostate Cancer
- Urine Based Diagnostic Test - Prostate Cancer Product Overview
- Advanced Marker Discovery SL - Key Competitors
- Advanced Marker Discovery SL - Key Employees
- Advanced Marker Discovery SL - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Advanced Marker Discovery SL, Recent Developments
- Jan 23, 2024: FDA Grants Breakthrough Device Designation to Amadix´s Preventive Screening Blood Test for Colorectal Cancer
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Table 1: Advanced Marker Discovery SL Pipeline Products and Ongoing Clinical Trials Overview
- Table 2: Advanced Marker Discovery SL Pipeline Products by Equipment Type
- Table 3: Advanced Marker Discovery SL Pipeline Products by Indication
- Table 4: Advanced Marker Discovery SL, Key Facts
- Table 5: Advanced Marker Discovery SL, Major Products and Services
- Table 6: Advanced Marker Discovery SL Number of Pipeline Products by Development Stage
- Table 7: Advanced Marker Discovery SL Pipeline Products Summary by Development Stage
- Table 8: nd Generation Prostate Cancer Test - Product Status
- Table 9: nd Generation Prostate Cancer Test - Product Description
- Table 10: rd Generation Prostate Cancer Test - Product Status
- Table 11: rd Generation Prostate Cancer Test - Product Description
- Table 12: th Generation Prostate Cancer Test - Product Status
- Table 13: th Generation Prostate Cancer Test - Product Description
- Table 14: Biomarker Diagnostic Test - Ovarian Cancer - Product Status
- Table 15: Biomarker Diagnostic Test - Ovarian Cancer - Product Description
- Table 16: DiagnoLung - Product Status
- Table 17: DiagnoLung - Product Description
- Table 18: PancreaDix - Product Status
- Table 19: PancreaDix - Product Description
- Table 20: Predictive Diagnostic Test - Lung Cancer - Product Status
- Table 21: Predictive Diagnostic Test - Lung Cancer - Product Description
- Table 22: PreveCol - Product Status
- Table 23: PreveCol - Product Description
- Table 24: Prognostic And Predictive Test - Colon cancer - Product Status
- Table 25: Prognostic And Predictive Test - Colon cancer - Product Description
- Table 26: Prognostic Test - Lung Cancer - Product Status
- Table 27: Prognostic Test - Lung Cancer - Product Description
- Table 28: Prognostic Test - Prostate Cancer - Product Status
- Table 29: Prognostic Test - Prostate Cancer - Product Description
- Table 30: Prostate Cancer - Genetic Test - Product Status
- Table 31: Prostate Cancer - Genetic Test - Product Description
- Table 32: Urine Based Diagnostic Test - Prostate Cancer - Product Status
- Table 33: Urine Based Diagnostic Test - Prostate Cancer - Product Description
- Table 34: Advanced Marker Discovery SL, Key Employees
- Table 35: Advanced Marker Discovery SL, Other Locations
- Table 36: Advanced Marker Discovery SL, Subsidiaries
- Table 37: Glossary
- List of Figures
- Figure 1: Advanced Marker Discovery SL Pipeline Products by Equipment Type
- Figure 2: Advanced Marker Discovery SL Pipeline Products by Development Stage
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.